Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

Sermo Healthcare Community Expands Payer & Oncologist Reach To Support Evolving Industry Needs

Sermo

Sermo, a physician-first online community and leader in global healthcare professional (HCP) insights, has expanded its platform to offer industry customers on-demand access to critical payer insights and the opportunity to build stronger connections with oncologists at a time when cancer treatment innovations are on the rise globally. The recent acquisitions of Payer Access, a leading insights provider in the U.S. payer and hospital decision-maker market followed by Charter Oak, a premier healthcare research company, support and amplify payers and oncologists on Sermo. Now, Sermo provides comprehensive reach across HCPs, payers and expert healthcare decision-makers within a single platform. Sermo’s reach into the U.S. payer market exceeds 230 million commercial lives covered. With the inclusion of Pharmacy Benefit Management companies, their reach covers virtually every commercial life in the United States. Pharmaceutical and medical device companies can leverage this highly coveted group to inform successful go-to-market strategies ranging from new product receptivity to defining win-win contracting terms. In addition to the payers expansion, Sermo is dedicated to building the Sermo Oncology Community further through its multi-channel recruitment and engagement strategy. Given the highly competitive oncology market and an ASCO-projected shortage of more than 2,200 oncologists by 2025, trusted oncologists’ insights and engagements are in high demand by the entire healthcare ecosystem. Since 2018, Sermo’s global Oncology community has grown by 28% and is projected to reach 42,000+ by the end of 2023. The growth enables Sermo to connect with more oncologists, make their voices heard on the platform and share vital insights to inform healthcare decisions around the world. “This strategic expansion is a testament to Sermo’s ongoing growth trajectory and directly fills gaps in the healthcare industry’s needs,” said Sermo CEO, Peter Kirk. “With Sermo’s global reach of 1.3 million HCPs, acquisitions such as Charter Oak and Payer Access give us increased 360-degree market visibility, added connections to the oncology community and unique access to essential audiences that directly impact outcomes for millions.” As the healthcare industry continues to evolve and tackle important trends like an increase in cancer rates among patients globally, Sermo is committed to providing a trusted platform for real-time insights and engagements among crucial stakeholder groups. These acquisitions are important milestones in Sermo’s continued M&A and growth strategy. About Sermo: Sermo turns physician experience, expertise and observations into actionable insights for the global healthcare community. Engaging with more than 1.3 million HCPs across 150 countries as well as the U.S. payer community, Sermo provides a unique community that fosters impactful peer-to-peer collaboration and discussions about issues that are important to healthcare constituents and their patients. Sermo offers on-demand access to physicians via a suite of proprietary technology to provide business intelligence that benefits pharmaceutical, healthcare partners and the medical community at large. To learn more, visit www.sermo.com. Contact Details Sermo Kite Hill PR for Sermo sermo@kitehillpr.com Company Website https://www.sermo.com/

February 08, 2023 10:00 AM Eastern Standard Time

MGC Pharmaceuticals' "numbers were very good" in Q4 2022

MGC Pharmaceuticals Ltd

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief commercial officer Robert Clements speaks to Proactive's Thomas Warner about how the business performed during the fourth quarter of 2022. Clements says that the "numbers were very good" and reveals more details about how the business is changing as it heads into a new calendar year. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

February 08, 2023 08:47 AM Eastern Standard Time

Video

News Release

Skye Bioscience marks SBI-100 clinical trial progress with new clinical research organization

Skye Bioscience Inc

Skye Bioscience CEO Punit Dhillon joined Proactive's Natalie Stoberman to share the latest progress on its SBI-100 Ophthalmic Emulsion (OE) clinical trials. SBI-100 OE, the company's lead program, is focused on developing a treatment for glaucoma, the world's leading cause of irreversible blindness. Skye Bioscience is a pharmaceutical company unlocking the potential of cannabinoids through the development of its proprietary cannabinoid derivatives to treat diseases with significant unmet needs. Contact Details Proactive Investors US +1 347-449-0879 na-editorial@proactiveinvestors.com

February 08, 2023 07:19 AM Eastern Standard Time

Video

UC Asset Signed 2nd MoU to Speed Up Phase I of $4M Cannabis Deal

UC Asset LP

McapMediawire -- UC Asset LP (OTCQB: UCASU ) announced today that the company has signed second MOU on its recently announced deal of $4 million cannabis property transaction in the State of Oklahoma. Four weeks ago, UCASU entered into a MOU to acquire a 10,000 square foot cannabis cultivation property using $3 million non-cash payment, and to invest $1 million cash to build extra 5,000 square feet of facility at the same site. The new MOU details on what UCASU calls “Phase I” of the deal. In this Phase I, UC Asset will acquire 20% of ownership in the said property using non-cash payment of 500,000 preferred shares, and then will invest $1 million cash for the aforementioned expansion of the cultivation facility, while increasing UC Asset’s ownership to 50%. UC Asset will have the option to acquire the remained 50% ownership of the property by issuing 2 million preferred shares. “The updated plan of Phase I enables us to expediate the construction of the extra 5,000 square feet of cannabis cultivation facility, and therefore it will speed up the return from our investment,” claims Larry Wu, founder of UC Asset. “Now we are expecting to receive monthly payment after 3 months, in comparison to the previous plan under which we will only be paid after 6 months.” This expedition is a win-win solution for both parties, according to Wu. The State of Oklahoma will hold a special election in March to decide on marijuana legalization. It is projected that the result will be in favor of legalization. For this reason, it is very desirable to complete the said expansion of growing facility as soon as possible, possibly right after the legalization of recreational marijuana within the state. Most other terms and conditions remain the same, including the amount of monthly payment that UC Asset will receive, which will represent a 14.4% cash on cash annual return. It will still include protective terms for existing shareholders, so that the issuance of 500,000 preferred shares will not dilute the value of holdings by existing shareholders, particularly, it will not dilute dividends allocated to existing shareholders. This is possible since the preferred shares are not entitled to receive dividends unless converted into common shares, and the holder of preferred shares can only convert when revenue from the property has increased to a certain level. This 10,000 square foot cannabis property, according to UC Asset, is built to the state-of-art standard, with computerized and automatized environment control, and has the capacity to host full cycle cannabis production from creating clones/genetics to extracting cannabinoids. UC Asset has set a goal of $1 million gross profit for the year of 2023. And the speed-up of this deal will likely help UC Asset to reach that goal. About UC Asset LP UC Asset LP is a limited partnership formed for the purpose of investing in real estate with innovative strategies. For more information about UC Asset, please visit: www.ucasset.com Disclaimer: This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this news release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed. For More Information Contact: IR@UCasset.com Contact Details Larry Wu IR@UCasset.com Company Website http://www.ucasset.com/

February 07, 2023 12:43 PM Eastern Standard Time

Context Therapeutics announces positive responses in Phase 2 OATH clinical trial

Context Therapeutics

Context Therapeutics CEO Marty Lehr joined Proactive's Natalie Stoberman to announce two clinical responses from its Phase 2 OATH Clinical Trial. Lehr said two patients have achieved a confirmed partial response among the first 12 patients enrolled in the trial evaluating the potential of ONA-XR in combination with anastrozole to treat hormone receptor-positive metastatic endometrial cancer. The findings are encouraging as ONA-XR exhibits initial signals of clinical activity and confirmed tumor shrinkage, Lehr added. Contact Details Proactive Investors USA +1 347-449-0879 na-editorial@proactiveinvestors.com

February 07, 2023 12:21 PM Eastern Standard Time

Video

News Release

Avicanna completes first international export of cannabis seeds between Colombia and Spain

Avicanna Inc

Avicanna CEO Aras Azadian joined Proactive's Natalie Stoberman to discuss the completion of its first export of feminized cannabis seeds to Spain. Azadian said the company's majority-owned Colombian subsidiary, Santa Marta Golden Hemp SAS, sent its first commercial export of feminized cannabis seeds to Spain. The seeds are part of the Aureus portfolio of products which also includes proprietary genetics in the form of feminized seeds, cannabinoid extracts and purified compounds including CBD, CBG and THC. Contact Details Proactive Canada +1 604-688-8158 na-editorial@proactiveinvestors.com

February 07, 2023 12:14 PM Eastern Standard Time

Video

News Release

Braxia Scientific signs non-binding letter of intent to sell company to Irwin Naturals

Braxia Scientific Corp.

Braxia Scientific CEO Dr Roger McIntyre joined Steve Darling from Proactive to share news the company has agreed to a non-binding amended and restated letter of intent for a business combination with Irwin Naturals Inc. McIntyre told Proactive the transaction assembles an experienced management and scientific team in mental health treatment, research and development. The combined company will have 17 specialized mental health clinics across North America, an enhanced telehealth platform and access to critical treatments for millions of people across multiple states in the US. Contact Details Proactive Canada +1 604-688-8158 na-editorial@proactiveinvestors.com

February 07, 2023 12:02 PM Eastern Standard Time

Video

Intus Care Announces Oracle Health Chairman Dr. David Feinberg Has Joined Its Board of Directors

Intus Care

Intus Care, developer of an innovative predictive analytics platform designed for geriatric health, today announced that David Feinberg, MD, Chairman of Oracle Health, has joined its esteemed board of directors. David is committed to making healthcare more accessible, affordable, and equitable. His goals are well-aligned with Intus Care’s mission of enabling more effective geriatric care by empowering care providers through data to make more informed decisions. David’s work at Oracle has served to advance access to critically needed data through an open and connected healthcare ecosystem. Previously, David served as president and CEO of Cerner, the healthcare IT industry leader which was acquired by Oracle in June of 2022. David led Cerner teams focused on delivering tools and technology to improve the patient and caregiver experience. “As CEO of Cerner, and now in his role at Oracle, few people understand the healthcare IT landscape and the importance of empowering care providers with better technologies like David does,” said Robbie Felton, CEO, Intus Care. “He recognizes the value of leveraging patient data in more meaningful ways, a mission which Intus Care shares.” Intus Care is continuing to expand its PACE partnerships and aiming to scale its work with special needs plans and other senior care entities across the healthcare spectrum to provide high quality care to vulnerable older adult populations. “I’m excited to join the Intus Care Board of Directors. The work they’re doing is going to allow data that care providers are already collecting to go much further in terms of improving care outcomes,” said David. “Intus Care is already proving through its work with PACE programs across the country that they have what it takes to allow routine data to be used to make hard-to-see correlations that can reduce patient complications and improve overall patient care.” Prior to his position at Cerner, David served as president and CEO of both UCLA Health and Geisinger Health prior to assuming leadership of Google Health in early 2019. He earned his MD from Chicago Medical School in 1989, finishing at the top of his class and is a member of the Alpha Omega Alpha Medical Honor Society. He also holds an economics degree from the University of California-Berkeley and an MBA from Pepperdine University. About Intus Care Intus Care synthesizes data to improve care and reduce hospitalizations for some of the most socially vulnerable and clinically complex patients in today’s healthcare system – senior citizens. Through a unique predictive analytics platform and data-driven consulting services, Intus Care empowers managed care organizations such as PACE programs, special needs plans, long-term care facilities, and more. It integrates with existing electronic health records, claims, and financial software to automatically extract and analyze data. By highlighting participant risk and data-driven improvement strategies, Intus Care empowers providers and organizations to improve outcomes. Visit our website to learn more and to sign up for our newsletter intuscare.com. PR Contact Jordan Bouclin and Erika Harris SVM Public Relations and Marketing Communications intuscare@svmpr.com (401)490-9700 Contact Details SVM Public Relations +1 401-490-9700 intuscare@svmpr.com Company Website https://www.intuscare.com/

February 07, 2023 10:00 AM Eastern Standard Time

Uninsured And Underinsured Americans Are Saving 10% To 60% On Dental Care Thanks To DentalPlans.com

DentalPlans.com

By Rachael Green, Benzinga Open enrollment for employer-sponsored health insurance ended last week in most states, but an estimated 29% of adults still don’t have dental coverage. That’s due, in part, to the fact that dental care is often treated as something separate from healthcare. The Affordable Care Act doesn’t even include dental coverage as part of its ten essential health benefits that all plans must include, despite the fact that poor oral health has been linked to heart disease and other serious chronic health problems. The good news for those millions of Americans who missed out on dental insurance: dental savings plans are open to join year-round and can reduce the cost of dental care by 10% to 60% depending on the procedure and plan. DentalPlans.com, a leading marketplace of dental savings plans operating since 1999, makes it easy to find the right savings plan to make quality oral health affordable regardless of insurance status. Oral Health Is More Important Than You Might Think While it’s not classified as essential, the data proves that oral health is extremely important to our overall health. Bacteria and inflammation that start in the mouth can also spread to other areas and contribute to other health problems like heart disease, poor pregnancy outcomes and pneumonia. Chronic health conditions like diabetes and osteoporosis have also been linked to increased risk for gum disease and tooth decay. Physical health aside, missing teeth and other signs of poor oral health can hurt a person’s financial and social well-being, too. According to the American Dental Association, 30% of low-income adults face limitations in job interviews due to the condition of their mouth and teeth. Dental Savings Plans Help Make Improved Oral Health More Accessible Despite the growing body of research that shows how important oral health is to a person’s overall health and quality of life, dental care is still not covered by original Medicare and most state Medicaid programs include either no coverage at all, limited coverage for emergency care only, or coverage that’s capped at low annual maximums. In states that do provide coverage, those annual maximums range from just $500 in Arkansas up to $1,150 in Alaska. Even most private dental plans come with annual maximums that cap out at under $2,000 on average. Those annual limits are rarely enough to cover the full cost of even one big ticket procedure, like dental implants or root canals. As a result, adults who need anything beyond routine cleanings and exams either have to foot the bill for dental work themselves or look for supplemental plans to cover this gap in coverage. That’s where DentalPlans.com comes in. The dental savings plans marketplace provides a searchable database where visitors can find a dental savings plan that offers savings at their preferred dentist or discounts for the specific procedure they need. In exchange for a low annual membership fee, plan members of a dental savings plan enjoy discounts of between 10% to 60% off of the full price of dental procedures ranging from routine cleanings and exams to more specialized restorative and orthodontic procedures. More than 140,000 dentists, representing over 70% of practicing dentists in the United States, participate in dental savings plans. Once they join, a plan member simply has to show their membership card at the participating dentist’s office to get the discounted rate. Plans activate quickly and there are no annual limits or restrictions based on current health conditions. In one example provided on the site, a family of two adults and two children pays an annual family membership fee of $209.95 for the Careington Care 500 Series savings plan. Without the plan, a routine six-month checkup would cost $73 per person, a teeth cleaning visit would cost $122 per adult and $84 per child, and x-rays would cost $80 per person. That means the standard preventative care recommended would cost $1,316 for the family without insurance. With the example savings plan, a routine six-month checkup costs $19 per person, a teeth cleaning visit costs $39 per adult and $31 per child, and x-rays cost $21 per person. Those discounts bring the total cost for the family down to $396, representing over 55% savings even when you add the annual membership fee back in. Sample savings are based on zip code 43614, actual costs and savings may vary by service and geographical area. If anyone in that family also needed restorative care like fillings, crowns, or root canals, their dental savings plan would allow them to save hundreds or thousands on those more expensive and very important procedures. For those without dental insurance, a dental savings plan can make essential preventative care affordable and substantially lower the cost of restorative and emergency dental care. For those with dental insurance, the discounts that come with membership can help lower the out-of-pocket costs they are responsible for after they surpass their insurance plan’s annual maximum. While the two can’t be used on the same procedure, dentists can help patients who need multiple procedures (such as a root canal followed by a crown and filling) coordinate a care plan that maximizes their insurance coverage and their dental savings plan discounts. To learn more visit DentalPlans.com This article was originally published on Benzinga here. DentalPlans.com, founded in 1999, is a leading online marketplace for dental savings plans in the U.S., helping more than a million people to affordably access quality healthcare services. Our mission is to empower consumers with the tools, information, and services that they need to live happier, healthier lives. This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Contact Details Matthew Wong matthew.wong@wpromote.com Company Website https://www.dentalplans.com/

February 07, 2023 09:15 AM Eastern Standard Time

1 ... 163 164 165 166 167 ... 308